Gilead Sciences, Inc. (NASDAQ: GILD) shares rose 4.3% to $117.91 as the company reported better-than-expected earnings for the second quarter and raised its FY15 sales forecast. Share volume was 8.4 million, compared to an all-day average of 10.9 million
